Articles
Risk in Focus :: Real Estate Q1 2023
Thursday, March 16, 2023
We’ll explore four significant risks faced by Commercial Real Estate investors and landlords along the controllable/noncontrollable spectrum
Losses from AI in Healthcare: Who is Liable?
Thursday, March 9, 2023
While there has been continual growth in this area year over year, we began to see significant investment in AI in the healthcare sector at the onset of the COVID-19 pandemic. Since then, we’ve continued to see a steady increase, which is projected to carry on.
Markets in Focus :: Healthcare Q1 2023
Wednesday, March 8, 2023
Just when the healthcare industry and its frontline caregivers were recovering from more than two years of managing enormous COVID-19 patient loads, the “triple threat” of COVID-19, influenza and RSV arrived with a vengeance in early fall.
Executive Risk Solutions
Monday, March 6, 2023
The decreased number of IPOs and de-SPAC transactions in 2022 had a positive impact on pricing, resulting in increased competition between D&O carriers for existing company business. To learn more please read our latest Executive Risk Solutions Report
Markets in Focus :: Cyber Q1 2023
Thursday, February 23, 2023
The underlying theme of Cyber risk remains volatility – for both insured and insurer. While Cyber insurance has been available for over twenty years, it has only come into mainstream focus in the past five years due to the prevalence of ransomware attacks. Prior to that, Cyber insurance was seen as mainly an instrument to manage data breaches and privacy. Ransomware has demonstrated that Cyber risk is not limited to theft of data and is truly an enterprise risk.
Rx Reporting – Round Two! (Sorry, you can’t ignore it this time.)
Thursday, February 16, 2023
We’ve made it through the first round of prescription drug reporting (a/k/a RxDC reporting) required by the Consolidated Appropriations Act. The reports for 2020 and 2021 were initially due December 27, 2022 which deadline was later extended to January 31, 2023.
Auto Insurance? But I Don’t Own a Fleet of Vehicles!
Thursday, February 16, 2023
Driving is a high-risk activity that can create significant exposure for businesses, even if transportation is not a core component of operations. Non-owned vehicle exposure is an often-overlooked risk that can be managed in various ways.
Markets in Focus :: General Q1 2023
Wednesday, February 15, 2023
COVID-19 caused a quick shift in the insurance industry in a number of ways. Technology is now more essential than ever in order for companies to run smoothly utilizing a virtual workspace.¹ As a result of the low-interest rates, demand for liquidity and the possibility of unexpected occurrences, organizations are being forced to modify their practices and specialize their insurance programs.
Risk in Focus :: Advanced Manufacturing Q1 2023
Wednesday, February 1, 2023
RISK in Focus is an overview to show recent risks in the workplace, on the jobsite and throughout the world.
A comprehensive review of hazards that contribute to the risks are spelled out to help you learn and avoid these hazards for yourself and your company.
Washington Partnership Access Line Fund
Thursday, January 26, 2023
The Partnership Access Line (“PAL”) is actually four services that assist healthcare providers in the management of their patients’ psychiatric needs and connecting their patients to care and support. In 2020, the Washington legislature passed a bill that established the WAPAL Fund and directed the Health Care Authority (HCA) to collect a quarterly assessment fee from Washington health carriers and self-insured plans based on the number of covered lives in their plans which would go toward funding the PAL program services.
Telemedicine & HSA Relief Included in 2023 Consolidated Appropriations Act (CAA)
Thursday, December 29, 2022
Earlier this week, Congress released the language of their year-end government funding bill, 2023 CAA, which included a two-year extension of this telehealth relief for HSA participants. The 2023 CAA bill has now been signed into law.
New Guidance and Delayed Enforcement for Prescription Drug Data Collection (RxDC)
Wednesday, December 28, 2022
On the eve of the requirement for employer sponsored health plans and health insurance carriers to submit prescription drug cost reporting data, the Departments of Labor, Health and Human Services, and the Treasury (collectively, the Departments), issued new guidance, and provided a submission grace period through January 31, 2023.
Twitter
LinkedIn
Facebook
YouTube